Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 8Small Cell Lung Carcinoma 4Colorectal Neoplasms 4Rectal Neoplasms 3Prostatic Neoplasms 2Neoplasm Metastasis 2Multiple Myeloma 2Colonic Neoplasms 2Carcinoma, Intraductal, Noninfiltrating 2Breast Carcinoma In Situ 2Waldenstrom Macroglobulinemia 1Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Smoldering Multiple Myeloma 1Pancreatic Neoplasms 1Neoplasms, Plasma Cell 1Margins of Excision 1Lung Neoplasms 1Leiomyoma 1Fibrosis 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Brain Neoplasms 1Biliary Tract Neoplasms 1

Interventions

Indocyanine Green 2Everolimus 2Sunitinib 1Simvastatin 1Interferon alpha-2 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Margins of Excision × Simvastatin × Clear all
NCT04418089 2020-06-05

Simvastatin Effect in Combination With Neoadjuvant Chemotherapy to Clinical Response and Tumor-Free Margin in Locally Advanced Breast Cancer

Indonesia University

Phase 2 Completed
60 enrolled
Breast

Margins of Excision, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡